Form 8-K - Current report:
SEC Accession No. 0001823239-25-000033
Filing Date
2025-03-18
Accepted
2025-03-18 16:08:22
Documents
14
Period of Report
2025-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrvi-20250317.htm   iXBRL 8-K 34474
2 EX-99.1 exhibit991-q42024.htm EX-99.1 221970
  Complete submission text file 0001823239-25-000033.txt   406922

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrvi-20250317.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrvi-20250317_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrvi-20250317_pre.xml EX-101.PRE 13046
16 EXTRACTED XBRL INSTANCE DOCUMENT mrvi-20250317_htm.xml XML 2833
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39725 | Film No.: 25748323
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)